World Library  
Flag as Inappropriate
Email this Article

Trypanosomiasis

Article Id: WHEBN0000644499
Reproduction Date:

Title: Trypanosomiasis  
Author: World Heritage Encyclopedia
Language: English
Subject: History of HIV/AIDS, Leishmania mexicana, Tsetse fly, Fulani herdsmen, Health in Burundi
Collection: Protozoal Diseases
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Trypanosomiasis

Trypanosomiasis
Classification and external resources
ICD-10 B56-B57
ICD-9-CM 086.5-086
MeSH D014352

Trypanosomiasis or trypanosomosis is the name of several diseases in vertebrates caused by parasitic protozoan trypanosomes of the genus Trypanosoma.

In humans this includes African trypanosomiasis and Chagas disease. A number of other diseases occur in other animals. Chagas disease

Approximately 30,000 people in 36 countries of sub-Saharan Africa have African trypanosomiasis, which is caused by either Trypanosoma brucei gambiense or Trypanosoma brucei rhodesiense.[1][Chagas disease causes 21,000 deaths per year mainly in Latin America).[2]

Contents

  • Signs and symptoms 1
  • Treatment 2
  • Other animals 3
    • Clinical signs and diagnosis 3.1
    • Prevention 3.2
  • Bibliography 4
  • References 5
  • External links 6

Signs and symptoms

The tsetse fly bite erupts into a red chancre sore and within a few weeks, the person can experience fever, swollen lymph glands, blood in urine, aching muscles and joints, headaches and irritability. In the first phase, the patient has only intermittent bouts of fever with lymphadenopathy together with other non-specific signs and symptoms. The second stage of the disease is marked by involvement of the central nervous system with extensive neurological effects like changes in personality, alteration of the biological clock (the circadian rhythm), confusion, slurred speech, seizures and difficulty in walking and talking. These problems can develop over many years and if not treated, the person dies. It is common to the African continent.

Treatment

Diagnosis is often missed in the first phase of the disease due to non-specific nature of symptoms. Pentamidine and Suramin are used for treatment in the first phase. Melarsoprol, nifurtimox and eflornithine are drugs used in second phase of the disease. However none of the therapies available are optimal in terms of adverse events and ease of administration.[3]

Other animals

Chagas endemic zones (in red)

Some species of cattle such as the African buffalo, N'dama, and Keteku appear trypanotolerant and do not develop symptoms. Calves are more resistant than adults.

Clinical signs and diagnosis

Cattle may show enlarged lymph nodes and internal organs. Haemolytic anaemia is a characteristic sign. Systemic disease and reproductie are common, and cattle appear to waste away.

Horses with dourine show signs of ventral and genital edema and urticaria.

Infected dogs and cats may show severe systemic signs.

Diagnosis relies on recognition of the buffy coat when a blood sample is spun down. Serological testing is also common.

Prevention

Diminazene, homidium, isometadium, suramin, and melarsomine can all be used to treat infections. Resistance is increasing in endemic areas and recurrent treatments may be necessary.[4]

The use of trypanotolerant breeds for livestock farming should be considered if the disease is widespread.

Fly control is another option but is difficult to implement.

The main approaches to controlling African trypanosomiasis are to reduce the reservoirs of infection and the presence of the tsetse fly. Screening of people at risk helps identify patients at an early stage. Diagnosis should be made as early as possible and before the advanced stage to avoid complicated, difficult and risky treatment procedures.

Bibliography

  • Thomas, H Wolferstan (1905). Report on trypanosomes, trypanosomiasis, and sleeping sickness : being an experimental investigation into their pathology and treatment. London: University Press of Liverpool.  
  •  
  • Daniels, Charles Wilberforce (1914). Tropical Medicine and Hygiene. New York.  
  • Maudlin, Ian; Holmes, Peter; Miles, Michael W (2004). The trypanosomiases. Wallingford, UK; Cambridge, MA: CABI Publishing.  

References

  1. ^ WHO. "Trypanosomiasis, Human African (sleeping sickness)". Fact sheet N°259. World Health Organization. Retrieved 25 February 2014. 
  2. ^ Maya JD, Cassels BK, Iturriaga-Vásquez P, et al. (2007). "Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host". Comp. Biochem. Physiol., Part a Mol. Integr. Physiol. 146 (4): 601–20.  
  3. ^ Lutje, V; Seixas, J; Kennedy, A (Jun 28, 2013). "Chemotherapy for second-stage human African trypanosomiasis.". The Cochrane database of systematic reviews 6: CD006201.  
  4. ^ Carsten Wrenger, Isolmar Schettert, Eva Liebau (2013). "Oxidative stress in human infectious diseases – present and current knowledge about its druggability". Drug Development. InTech.  

External links

  • Animal Trypanosomosis reviewed and published by Wikivet.
  • Disease card on World Organisation for Animal Health
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.